Medical Properties Trust (MPW) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Medical Properties Trust (NYSE:MPW) from a sell rating to a hold rating in a research note released on Tuesday.

According to Zacks, “Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. These facilities include inpatient rehabilitation hospitals, long-term acute care hospitals, regional and community hospitals, women’s and children’s hospitals, skilled nursing facilities, ambulatory surgery centers, and other single-discipline healthcare facilities, such as heart hospitals, orthopedic hospitals and cancer centers. “

MPW has been the topic of several other reports. ValuEngine raised shares of Medical Properties Trust from a hold rating to a buy rating in a report on Thursday, November 9th. SunTrust Banks reaffirmed a buy rating and set a $15.00 price objective on shares of Medical Properties Trust in a report on Friday, November 3rd. Robert W. Baird downgraded shares of Medical Properties Trust from an outperform rating to a neutral rating and dropped their price objective for the company from $15.00 to $13.00 in a report on Friday, January 5th. JPMorgan Chase & Co. raised shares of Medical Properties Trust from an underweight rating to a neutral rating and set a $14.50 price objective on the stock in a report on Friday, December 15th. Finally, Deutsche Bank downgraded shares of Medical Properties Trust from a buy rating to a hold rating and dropped their price objective for the company from $14.00 to $13.50 in a report on Wednesday, January 10th. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus price target of $14.30.

Shares of Medical Properties Trust (MPW) traded up $0.07 during trading hours on Tuesday, hitting $12.90. 1,705,183 shares of the company were exchanged, compared to its average volume of 2,280,000. The company has a quick ratio of 2.55, a current ratio of 2.55 and a debt-to-equity ratio of 1.26. The stock has a market cap of $4,700.00, a P/E ratio of 16.97, a P/E/G ratio of 1.57 and a beta of 0.96. Medical Properties Trust has a 52 week low of $11.90 and a 52 week high of $14.22.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.32 by $0.01. The business had revenue of $176.60 million for the quarter, compared to the consensus estimate of $172.57 million. Medical Properties Trust had a net margin of 39.95% and a return on equity of 7.36%. The company’s revenue was up 39.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.30 earnings per share. analysts predict that Medical Properties Trust will post 1.33 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Thursday, January 11th. Stockholders of record on Thursday, December 7th were issued a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.44%. The ex-dividend date of this dividend was Wednesday, December 6th. Medical Properties Trust’s payout ratio is 126.32%.

Institutional investors have recently made changes to their positions in the company. Ffcm LLC purchased a new stake in shares of Medical Properties Trust in the third quarter worth about $116,000. Investors Asset Management of Georgia Inc. GA ADV purchased a new stake in shares of Medical Properties Trust in the fourth quarter worth about $138,000. Mcmillion Capital Management Inc. purchased a new stake in shares of Medical Properties Trust in the third quarter worth about $137,000. Janus Henderson Group PLC purchased a new stake in shares of Medical Properties Trust in the second quarter worth about $136,000. Finally, Cetera Investment Advisers bought a new position in shares of Medical Properties Trust in the second quarter worth approximately $141,000. 81.20% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Medical Properties Trust (MPW) Upgraded at Zacks Investment Research” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/20/medical-properties-trust-mpw-upgraded-at-zacks-investment-research.html.

About Medical Properties Trust

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply